HealthDay

FDA Approves First Test for Zika in Human Blood

FRIDAY, May 31, 2019 (Pharmacist's Briefing) -- The first test to detect the Zika virus in human blood has been approved by the U.S. Food and Drug Administration
Read More

HealthDay

Excess Cause-Specific Mortality Tied to Chronic Proton Pump Inhibitor Use

FRIDAY, May 31, 2019 (Pharmacist's Briefing) -- Taking proton pump inhibitors (PPIs) is associated with an excess of cause-specific mortality, according to a study published online May 30 in The BMJ
Read More

HealthDay

CDC: Reported Measles Cases Reach 971

FRIDAY, May 31, 2019 (Pharmacist's Briefing) -- Five months into 2019, the number of measles cases in the United States has now reached 971, the largest number since 1992 when 963 total cases were reported for the year, the U.S. Centers for Disease Control and Prevention announced
Read More

HealthDay

U.S. Dentists Prescribe Opioids More Often Than U.K. Dentists

THURSDAY, May 30, 2019 (Pharmacist's Briefing) -- The proportion of prescriptions for opioids written by dentists in the United States was 37 times greater than the proportion of opioid prescriptions written by English dentists in 2016, according to a study published online May 24 in JAMA Network Open
Read More

HealthDay

Daratumumab Cuts Risk for Progression in Multiple Myeloma

THURSDAY, May 30, 2019 (Pharmacist's Briefing) -- For patients with newly diagnosed multiple myeloma, the addition of daratumumab to lenalidomide and dexamethasone is associated with a reduced risk for disease progression or death, according to a study published in the May 30 issue of the New England Journal of Medicine
Read More

HealthDay

Inappropriate Prescribing Leads to Poor Outcomes in Older Adults

WEDNESDAY, May 29, 2019 (Pharmacist's Briefing) -- Potentially inappropriate prescribing (PIP) is tied to increased health care utilization and poor outcomes among older individuals seen in primary care practices, according to a review published in the May/June issue of the Annals of Family Medicine
Read More

HealthDay

Hip Fracture Linked to Increased Risk for Death in T2DM Patients

WEDNESDAY, May 29, 2019 (Pharmacist's Briefing) -- For patients with type 2 diabetes, hip fracture is associated with an increased risk for death, according to a study published online May 21 in the Journal of Diabetes Investigation
Read More

HealthDay

Reading Visit Notes May Improve Medication Management

WEDNESDAY, May 29, 2019 (Pharmacist's Briefing) -- Reading clinical notes can help patients to understand why medications are prescribed and improves medication adherence for some patients, according to a brief research report published online May 28 in the Annals of Internal Medicine
Read More

HealthDay

Energy Drinks Prolong QTc Interval, Elevate Blood Pressure

WEDNESDAY, May 29, 2019 (Pharmacist's Briefing) -- Energy drinks prolong the QTc interval and are associated with an increase in blood pressure, according to a study published online May 29 in the Journal of the American Heart Association
Read More

HealthDay

Drug Approvals

Updated: May 28, 2019
Read More

HealthDay

Drug Shortages

Updated: May 28, 2019
Read More

HealthDay

Drug Recalls

Updated: May 28, 2019
Read More

HealthDay

FDA Approves First Gene Therapy for Spinal Muscular Atrophy

TUESDAY, May 28, 2019 (Pharmacist's Briefing) -- The first gene therapy has been approved to treat children younger than 2 years with spinal muscular atrophy (SMA), the U.S. Food and Drug Administration announced Friday
Read More

HealthDay

First PI3K Inhibitor Approved for Metastatic, Advanced Breast Cancer

TUESDAY, May 28, 2019 (Pharmacist's Briefing) -- Piqray (alpelisib) tablets were approved for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer in combination with fulvestrant, the U.S. Food and Drug Administration announced Friday
Read More

HealthDay

U.S. Lawmakers Say WHO Opioid Guidelines Too Lax

FRIDAY, May 24, 2019 (Pharmacist's Briefing) -- The World Health Organization's pain care guidelines contain false claims about the safety of prescription opioid painkillers and should be withdrawn, two U.S. lawmakers say
Read More

HealthDay

Most Patients at High Risk of Opiate Overdose Do Not Receive Naloxone Rx

FRIDAY, May 24, 2019 (HealthDay News) -- Patients at high risk of opioid overdose rarely receive prescriptions for naloxone, despite many interactions with the health care system, according to a study published online May 3 in JAMA Network Open
Read More

HealthDay

California Bill to Tighten Vaccine Exemptions Moves Forward

THURSDAY, May 23, 2019 (Pharmacist's Briefing) -- A bill that would tighten control over vaccination exemptions for children in California was sent by state senators to the Assembly on Wednesday
Read More

HealthDay

High-Deductible Health Plans May Be Harmful for Patients With COPD

THURSDAY, May 23, 2019 (Pharmacist's Briefing) -- For patients with chronic obstructive pulmonary disease (COPD), high-deductible health plans (HDHPs) are associated with increased likelihood of reporting foregoing care because of costs and cost-related nonadherence, according to a study presented at the American Thoracic Society 2019 International Conference, held from May 17 to 22 in Dallas
Read More

HealthDay

Half-Price Version of Humalog Insulin Now Available

THURSDAY, May 23, 2019 (Pharmacist's Briefing) -- A half-price version of Humalog insulin is now available in the United States, Eli Lilly said Wednesday
Read More

HealthDay

CDC: Seniors Use Various Strategies to Reduce Rx Costs

WEDNESDAY, May 22, 2019 (Pharmacist's Briefing) -- A proportion of older adults employ strategies to reduce prescription drug costs, according to a May data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics
Read More

HealthDay

Treatment Rates Low for Parents With Opioid Use Disorder

WEDNESDAY, May 22, 2019 (Pharmacist's Briefing) -- Rates of treatment are low for parents with opioid use disorder (OUD) or other substance use disorders (SUDs), according to a study published in the May/June issue of the Annals of Family Medicine
Read More

HealthDay

Poor Broadband Penetration in Rural Areas Limits Telemedicine

TUESDAY, May 21, 2019 (Pharmacist's Briefing) -- Broadband penetration rates are considerably lower in the most rural counties, especially where access to primary care physicians and psychiatrists is inadequate, according to a study published online May 21 in the Annals of Internal Medicine
Read More

HealthDay

Racial Disparity Seen in Prescriptions for Buprenorphine

TUESDAY, May 21, 2019 (Pharmacist's Briefing) -- Black patients are less likely to receive a buprenorphine prescription to treat opioid use disorder, according to a research letter published online May 8 in JAMA Psychiatry
Read More

HealthDay

Clinical Drug Diversion Costly to Health Care Organizations

TUESDAY, May 21, 2019 (Pharmacist's Briefing) -- U.S. health care organizations lost nearly $454 million due to clinical drug diversion in 2018, according to the 2019 Drug Diversion Digest, released by Protenus Inc
Read More

HealthDay

Private Insurers Pay 241 Percent of What Medicare Would Pay

MONDAY, May 20, 2019 (Pharmacist's Briefing) -- Prices paid to hospitals for privately insured patients in 2017 averaged 241 percent of what Medicare would have paid, with wide variation in prices among states, according to a report published by the RAND Corporation
Read More

HealthDay

One-Third of Patients on Statins Do Not Reach Target Thresholds

MONDAY, May 20, 2019 (Pharmacist's Briefing) -- More than one-third of patients on statin therapy fail to achieve therapeutic thresholds for low-density lipoprotein cholesterol (LDL-C), according to a study published in the May issue of the Journal of Managed Care & Specialty Pharmacy
Read More

HealthDay

First Anticoagulant Approved for Preventing VTE Recurrence in Children

FRIDAY, May 17, 2019 (Pharmacist's Briefing) -- Fragmin (dalteparin sodium) injection has been granted the first approval for subcutaneous use in preventing recurrence of symptomatic venous thromboembolism (VTE) in children aged 1 month or older, the U.S. Food and Drug Administration announced
Read More

HealthDay

FDA Approves Venetoclax for Chronic Lymphocytic Leukemia

FRIDAY, May 17, 2019 (Pharmacist's Briefing) -- Venetoclax (VENCLEXTA) has been approved to treat adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma, the U.S. Food and Drug Administration announced yesterday
Read More

HealthDay

Avelumab + Axitinib Approved for Treatment of Renal Cell Carcinoma

FRIDAY, May 17, 2019 (Pharmacist's Briefing) -- Avelumab (BAVENCIO) was approved this week for first-line treatment of advanced renal cell carcinoma (RCC) in combination with axitinib, the U.S. Food and Drug Administration announced
Read More

HealthDay

Sleep Duration Tied to Adverse Measures of Glycemia

FRIDAY, May 17, 2019 (Pharmacist's Briefing) -- Self-reported short and long sleep are both associated with adverse measures of glycemia among adults with prediabetes, according to a study published online May 10 in Diabetes Care
Read More